138 related articles for article (PubMed ID: 2041951)
1. Risk factors for candidemia in patients with acute lymphocytic leukemia.
Richet HM; Andremont A; Tancrede C; Pico JL; Jarvis WR
Rev Infect Dis; 1991; 13(2):211-5. PubMed ID: 2041951
[TBL] [Abstract][Full Text] [Related]
2. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
Lin MY; Carmeli Y; Zumsteg J; Flores EL; Tolentino J; Sreeramoju P; Weber SG
Antimicrob Agents Chemother; 2005 Nov; 49(11):4555-60. PubMed ID: 16251295
[TBL] [Abstract][Full Text] [Related]
3. Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer.
Blumberg EA; Reboli AC
Clin Infect Dis; 1996 Mar; 22(3):462-6. PubMed ID: 8852963
[TBL] [Abstract][Full Text] [Related]
4. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for disseminated candidiasis in children with candidemia.
Zaoutis TE; Greves HM; Lautenbach E; Bilker WB; Coffin SE
Pediatr Infect Dis J; 2004 Jul; 23(7):635-41. PubMed ID: 15247602
[TBL] [Abstract][Full Text] [Related]
6. Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient.
Mahieu LM; Van Gasse N; Wildemeersch D; Jansens H; Ieven M
Pediatr Crit Care Med; 2010 Mar; 11(2):240-5. PubMed ID: 19794324
[TBL] [Abstract][Full Text] [Related]
7. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study.
Sallah S; Wan JY; Nguyen NP; Vos P; Sigounas G
Cancer; 2001 Sep; 92(6):1349-53. PubMed ID: 11745210
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for candidemia in cancer patients: a case-control study.
Karabinis A; Hill C; Leclercq B; Tancrède C; Baume D; Andremont A
J Clin Microbiol; 1988 Mar; 26(3):429-32. PubMed ID: 3356785
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of nosocomial fungal infections, with emphasis on Candida species.
Jarvis WR
Clin Infect Dis; 1995 Jun; 20(6):1526-30. PubMed ID: 7548503
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity.
Kontoyiannis DP; Reddy BT; Hanna H; Bodey GP; Tarrand J; Raad II
Infect Control Hosp Epidemiol; 2002 Sep; 23(9):542-5. PubMed ID: 12269454
[TBL] [Abstract][Full Text] [Related]
11. Candida colonization and candidemia in a pediatric intensive care unit.
Singhi S; Rao DS; Chakrabarti A
Pediatr Crit Care Med; 2008 Jan; 9(1):91-5. PubMed ID: 18477920
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.
Saiman L; Ludington E; Pfaller M; Rangel-Frausto S; Wiblin RT; Dawson J; Blumberg HM; Patterson JE; Rinaldi M; Edwards JE; Wenzel RP; Jarvis W
Pediatr Infect Dis J; 2000 Apr; 19(4):319-24. PubMed ID: 10783022
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India.
Dewan E; Biswas D; Kakati B; Verma SK; Kotwal A; Oberoi A
Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):99-105. PubMed ID: 26173033
[TBL] [Abstract][Full Text] [Related]
14. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
[TBL] [Abstract][Full Text] [Related]
16. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
17. Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.
Colombo AL; Guimarães T; Silva LR; de Almeida Monfardini LP; Cunha AK; Rady P; Alves T; Rosas RC
Infect Control Hosp Epidemiol; 2007 May; 28(5):570-6. PubMed ID: 17464917
[TBL] [Abstract][Full Text] [Related]
18. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).
Hann I; Viscoli C; Paesmans M; Gaya H; Glauser M
Br J Haematol; 1997 Dec; 99(3):580-8. PubMed ID: 9401070
[TBL] [Abstract][Full Text] [Related]
19. Multiple-species candidemia in patients with cancer.
Boktour MR; Kontoyiannis DP; Hanna HA; Hachem RY; Girgawy E; Bodey GP; Raad II
Cancer; 2004 Oct; 101(8):1860-5. PubMed ID: 15386338
[TBL] [Abstract][Full Text] [Related]
20. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death.
Viudes A; Pemán J; Cantón E; Ubeda P; López-Ribot JL; Gobernado M
Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):767-74. PubMed ID: 12461585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]